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Figure 2. A. Representative X-ray images at IVD level L3L4 from acute long
term group. B. Disc height measurements pre- and post-injection. * P <
0.05 to BS-injected discs.
Figure 3. Selected lesion IVD catabolic enzyme gene expressions. Data
presented as fold change to NOC. *P < 0.05 between PBS and MSC.
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BMMSCs (107 cells/0.2ml PBS/disc) or PBS only (0.2ml) were injected
into the NP after 4 or 12 weeks of induction of IVDD (n¼6 sheep/group),
aftera further 8, 22 or 14week recoveryperiod the sheepwere sacriﬁced,
generating 3 study groups: Acute short term (Short), Acute long term
(Long), and Established IVDD (Est) (Fig 1B). The outcome measures for
this studywere histology, imaging (MRI, X-ray), gene proﬁling (qRTPCR),
biomechanical testing and biochemical composition analyses (Fig 1A).
Results: Induced IVD lesion led to siginﬁcant loss of disc height in all
lumbar levels (PBS injected, Fig 2). A re-attainment to 90-95% of pre-
lesion disc height was evident in MSC-injected discs (Fig 2). In the
Established group, MSC injected discs showed a recovery of proteo-
glycan (GAG) content to levels in NOC IVDs. Increased metal-
loproteinase activity is a feature of the ovine IVDD lesion model. It was
therefore signiﬁcant that MSC injection either normalised or inhibited
MMP2, 9, 13, ADAMTS4 or 5 expression in most lesion IVD tissue zones
(Fig 3). Biomechanical properties of IVDD at 3 and 6 months showed no
change in total range of motion, but signiﬁcantly increased neutral zone
measurements (NZ: range of displacement when IVD was unloaded
during movement), whereas BMMSC injected discs in Short and Est
groups returned NZ to NOC levels. Histology showed signiﬁcant
reduction in the propagation of the annular lesions in the MSC injected
discs, whereas in PBS injected discs the initial outer annular lesions
propagated through the mid-inner AF into and around the NP, and even
affecting the contralateral AF.
Conclusions: BMMSCs demonstrated considerable therapeutic promise
not only for the repair of a degenerate disc but also prevents/reduces
the progressive changes in established annular lesion: 1. Repair of
annular lesions and reduced IVDD pathology, 2. Recovery in disc
heights, GAG content of NP in Established disease, and biomechanical
properties of lesion discs, 3. Down-regulated MMP2, 9, 13, ADAMTS4
and 5 gene expressions. We identiﬁed a potential mechanism of action
of BMMSC to be the modulation of metalloproteinase expression. This
study has shown for the ﬁrst time in a large animal model relevant to
the human condition that BMMSC represent a clinically relevant ther-
apy for IVDD.42
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Purpose: The control of proliferation versus differentiation of mesen-
chymal stem cells (MSCs) is crucial for tissue homeostasis, remodelling,
and repair, as well as for tissue engineering strategies employing MSCs.
The transcriptional co-activator Yes-Associated Protein (YAP) has been
emerging as a key regulator of stem cells in tissues and organs such as
liver, intestine, brain and muscle. The purpose of this study was to
investigate whether YAP plays a role in regulating proliferation and
chondrogenic differentiation of MSCs.
Methods: Total YAP and phosphorylated (p)YAP were detected in con-
junction with nucleoside labels (to identify putative MSCs) by immu-
nostaining on parafﬁn sections of C57Bl/6mouse knee joints from either
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groove. To investigatewhether high YAP activity is sufﬁcient to drive the
proliferation ofMSCs, C3H10T1/2MSC-likemouse embryonicﬁbroblasts
were transduced with human (h)YAP variants, or empty vector, and
proliferation was measured using the EdU assay. In addition, R26-rtTA/
TRE-hYAP1(S127A) mice were treated with doxycycline for 4d to induce
ubiquitous expression of constitutively active hYAP1(S127A) orwere left
untreated and BrdU was given the ﬁnal 24h. Parafﬁn sections of knee
jointswere analysed histologically byH&E and stained for BrdU to assess
proliferation. To assess YAP expression during chondrogenesis, human
MSCswere cultured inmicromasswith orwithout TGFß1 for 6d, andYAP
expressionwas measured by quantitative RT-PCR using primers speciﬁc
for 9 currently known transcript variants. To determine the effect of high
YAP activity on chondrogenesis, hYAP-transduced C3H10T1/2 cells were
treated in micromass with BMP-2. Chondrogenic differentiation was
assessed by alcian blue staining and mRNA expression of the chon-
drocyte-lineage markers Sox9, Col2A1 and Col10A1. BMP signalling was
determined by detection of pSmad1,5,8 by western blotting and mRNA
expression of the BMP target genes Id1, Id2 and Id3.
Results: YAP protein expression in synovium increased following joint
surface injury when compared to uninjured control. Double-nucleo-
side-labelling showed that slow-cycling (stem) cells that proliferated in
response to injury expressed nuclear YAP. In contrast, pYAP (indicative
of YAP inhibition) was high in ectopic synovial cartilage forming in
response to patellar dislocation. Overexpression of hYAP in C3H10T1/2
cells signiﬁcantly increased cell proliferation, with constitutively active
hYAP1(S127A) or hYAP2(S127A) having a greater effect at high con-
ﬂuence or in absence of serum as compared to wild-type hYAP1 or
hYAP2. Induced expression of hYAP1(S127A) in mice resulted in syno-
vial thickening, and an increase in BrdUþ proliferating cells in syno-
vium, compared to mice not receiving doxycycline. A subset of BrdUþ
cells co-stained for the MSC marker Platelet-Derived Growth Factor
Receptor (PDGFR)a. Downregulation of YAP during chondrogenesis was
conﬁrmed in vitro with YAP mRNA expression lower in micromass
cultures of human synovial MSCs (5 donors) treated with TGFß1,
compared to vehicle-treated micromasses. All YAP transcript variants
were downregulated. Similar results were obtained with periosteal and
bone marrow MSCs. Overexpression of hYAP1, and to a greater extent
hYAP1(S127A), in C3H10T1/2 cells inhibited BMP-2-induced chondro-
genic differentiation compared to empty-vector transduced cells. High
YAP activity in these cells inhibited BMP signalling as judged by lower
levels of C-terminal Smad1,5,8 phosphorylation and decreased
expression of Id1, Id2 and Id3 in response to BMP-2 treatment. Similar
results were obtained for hYAP1 (containing 1WW domain) and hYAP2
(containing 2 WW domains) indicating that this does not require both
WW domains.
Conclusions: High YAP activity in MSCs promotes proliferation, while
downregulation of YAP is required for chondrogenesis possibly through
de-repressing chondrogenic signalling. These ﬁndings raise the possi-
bility that aberrant YAP activity in MSCs plays a role in the patho-
physiology of osteoarthritis, and that YAP may be a novel therapeutic
target for promoting joint repair and re-establishing joint homeostasis.
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DERIVATION OF TRANSPLANTABLE CARTILAGE FROM HUMAN
INDUCED PLURIPOTENT STEM CELLS
A. Yamashita, M. Morioka, Y. Yahara, M. Okada, N. Tsumaki. Kyoto Univ.,
Kyoto, Japan
Purpose: Articular cartilage injury or degeneration ultimately results in
the loss of joint function due to the cartilage’s lack of repair capacity.
Autologous chondrocyte transplantation and the use of MSC-derived
chondrocytes have been attractive methods for repairing the cartilage
defects. However, these methods suffer from the formation of ﬁbrous
repair tissue. In addition, it is difﬁcult to achieve integration of repair
tissue into the adjacent native cartilage. Recently, a new option for
repairing defects in articular cartilage has become available by applying
human induced pluripotent stem cells (hiPSCs) with self-renewal and
pluripotent capacities without ethical issues. The differentiation of
chondrocytes from human iPSCs / embryonic stem cells (ESCs) have
been reported. However, successful repair of a cartilage defect by hiPSC-
derived chondrocytes has not been reported. In this study, we focused
on the derivation of transplantable hiPSC-derived cartilage exhibiting
the ability to (i) generate pure hyaline cartilage in vivo, (ii) integrate
neocartilage into the adjacent native articular cartilage and (iii) produceneither tumors nor metastasis in immunodeﬁcient animals. We herein
developed a novel chondrogenic differentiation method by taking
advantage of real-time monitoring of the chondrocytic phenotype of
cells derived from COL11A2-EGFP hiPSCs. We then examined whether
the resultant hiPSC-derived cartilage met the above speciﬁcations using
animal transplantation models.
Methods: We ﬁrst generated hiPSC lines bearing the COL11A2-EGFP
transgene. The COL11A2-EGFP hiPSCs, when transplanted into immu-
nodeﬁciency mice, formed teratomas in which only the chondrocytes
expressed GFP. The COL11A2-EGFP hiPSCs were initially differentiated
into mesodermal cells, followed by treatment with chondrogenic sup-
plementation. By monitoring the GFP expression, we optimized the
content of the supplementation for cartilaginous nodule formation
from hiPSCs. On day 14, we exclusively detached the cartilaginous
nodules from the dish bottoms to form particles and transferred them
to a suspension culture. hiPSC-derived cartilaginous particles obtained
on day 42 were transplanted into the subcutaneous spaces of immu-
nodeﬁciency mice. In addition, hiPSC-derived cartilaginous particles
obtained on day 28 were transplanted into the joint surface defect of
immunodeﬁciency rat.
Results: We found that including GDF5 in the medium was critical for
the COL11A2-EGFP expression and thus chondrogenic differentiation of
the hiPSCs. During a suspension culture, hiPSCs-derived particles
gradually increased GFP ﬂuorescence and showed a white cartilaginous
appearance. In a histological analysis of the particles on day 42, we
obtained cartilaginous tissues indicated by Safranin O staining. The ratio
of SOX9-positive cells in the particles gradually increased, reaching 91.8
 0.91% on day 42 and almost 99.7  0.2% on day 56. Almost all cells
expressed COL11A2-EGFP on day 56. Thus, we could success chon-
drocyte puriﬁcation from hiPSCs in the generation of scaffold-free
homogenous cartilage without the use of cell sorting techniques in
vitro. Transplantation of the hiPSC-derived cartilaginous particles
generated stable hyaline cartilage that expressed type II collagen, but
neither type I nor type X collagen, in the subcutaneous space in the
immunodeﬁciency mice. Transplantation of these cartilaginous par-
ticles into joint surface defects resulted in the lateral integration of
neocartilage and native cartilage in immunodeﬁciency rats. These
immunodeﬁciency animals that underwent transplantation of the
hiPSC-derived cartilaginous particles suffered from neither tumors nor
metastasis for at least three months.
Conclusion: In this study, we demonstrated that the resultant hiPSC-
derived cartilage could be used to both generate stable pure cartilage
and induce integration into the adjacent native cartilage, which can be
hardly achieved with MSCs or autologous/allogeneic chondrocytes.
Most importantly, we did not observe any teratoma formation or distant
metastasis. Transplantable hiPSC-derived chondrocytes, which were
obtained using our simple protocol, are therefore a potentially viable
cell source for regenerating cartilage defects. Our demonstrations rep-
resent the ﬁrst step toward translating this procedure into clinical
applications in the near future.
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Purpose: Cell transplantation therapy is anticipated to regenerate car-
tilage defect. Mesenchymal stromal cells (MSCs) are one of promising
cell sources for cartilage repair due to their multipotency including
chondrocyte differentiation, ease of isolation and immune tolerance
ability. However there were few study that veriﬁed efﬁcacy and safety
of exercise as rehabilitation post cell transplantation. The aim of this
study was to assess whether exercise as rehabilitation promotes carti-
lage regeneration after MSCs transplantation therapy on cartilage
defect.
Methods: This experiment was approved by the animal research
committee of our facility. An osteochondral defect of 1mm diameter
was created on both femur grooves of thirty two Wistar rats at 8-week
